Septerna
This role involves developing quantitative in vitro protein-protein interaction assays for GPCR targets using innovative drug discovery technologies. The successful candidate will work within drug discovery project teams to create and advance novel plate-based displacement binding assays. The position offers the opportunity to contribute to a well-funded biotechnology company's mission to develop life-changing medicines.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Septerna is a biotechnology company developing GPCR-targeted medicines using its Native Complex Platform to discover and advance innovative therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Septerna.
Analysts Conflicted on These Technology Names: Fortinet (FTNT), Septerna, Inc. (SEPN) and Oracle (ORCL)
4 days ago